The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125244193 12524419 3 F 20160503 20160720 20160704 20160725 EXP HR-ROCHE-1786863 ROCHE 75.00 YR M Y 0.00000 20160725 MD HR HR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125244193 12524419 1 PS ROCEPHIN CEFTRIAXONE SODIUM 1 Intravenous (not otherwise specified) 63239 1 G TID
125244193 12524419 2 SS ROCEPHIN CEFTRIAXONE SODIUM 1 Intravenous (not otherwise specified) 63239 1 G TID
125244193 12524419 3 SS CONTROLOC PANTOPRAZOLE SODIUM 1 Intravenous (not otherwise specified) 0
125244193 12524419 4 C FURSEMID FUROSEMIDE 1 Intravenous (not otherwise specified) 0
125244193 12524419 5 C FURSEMID FUROSEMIDE 1 Intravenous (not otherwise specified) 0
125244193 12524419 6 C FURSEMID FUROSEMIDE 1 Intravenous (not otherwise specified) 0 500 MG
125244193 12524419 7 C DOBUTREX DOBUTAMINE HYDROCHLORIDE 1 Unknown 250 MG IN 50 ML OF PHYSIOLOGICAL SOLUTION 0 250 MG
125244193 12524419 8 C DOBUTREX DOBUTAMINE HYDROCHLORIDE 1 Unknown 500 MG IN 50 ML OF PHYSIOLOGICAL SOLUTION 0 500 MG
125244193 12524419 9 C DOBUTREX DOBUTAMINE HYDROCHLORIDE 1 Unknown 500 MG IN 50 ML OF PHYSIOLOGICAL SOLUTION 0 500 MG
125244193 12524419 10 C DULCOLAX NOS BISACODYL OR DOCUSATE SODIUM 1 Unknown 0 SUPPOSITORY
125244193 12524419 11 C KCL POTASSIUM CHLORIDE 1 Unknown 0
125244193 12524419 12 C NAHCO3 SODIUM BICARBONATE 1 Unknown 0
125244193 12524419 13 C PORTALAK (LACTULOSE) 2 Unknown 0
125244193 12524419 14 C NORMABEL DIAZEPAM 1 Unknown 3 AMPOULES IN 100 ML OF PHYSIOLOGICAL SOLUTION 0
125244193 12524419 15 C FRAGMIN DALTEPARIN SODIUM 1 Unknown 0 7500 IU
125244193 12524419 16 C FRAGMIN DALTEPARIN SODIUM 1 Unknown 0 7500 IU

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125244193 12524419 1 Product used for unknown indication
125244193 12524419 3 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125244193 12524419 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
125244193 12524419 Cardio-respiratory arrest
125244193 12524419 Metastatic carcinoma of the bladder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125244193 12524419 1 20160502 20160503 0
125244193 12524419 2 20160502 20160503 0
125244193 12524419 3 20160503 20160503 0
125244193 12524419 4 20160430 0
125244193 12524419 5 20160501 0
125244193 12524419 6 20160502 0
125244193 12524419 7 20160430 0
125244193 12524419 8 20160502 0
125244193 12524419 9 20160503 0
125244193 12524419 10 20160430 0
125244193 12524419 11 20160501 0
125244193 12524419 12 20160501 0
125244193 12524419 13 20160501 0
125244193 12524419 14 20160501 0
125244193 12524419 15 20160502 0
125244193 12524419 16 20160503 0